Intec Pharma Ltd.
Healthcare · Pharmaceutical Preparations · L3 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | −$13.8M | −$47.1M | −$43.3M | −$29.4M |
| Net income | −$14.1M | −$47.6M | −$43.5M | −$28.9M |
| Total assets | $20.9M | $21.3M | $61.5M | $64.5M |
| Total liabilities | $6.4M | $9.7M | $8.0M | $5.7M |
| Equity | $14.5M | $11.5M | $53.5M | $58.8M |
| EPS (diluted) | — | — | — | — |
| Shares out. | 53.0M | 33.2M | 33.2M | 26.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- —
- Net margin
- —
- Return on equity
- −97.2%
- Return on assets
- −67.6%
- Return on capital (ROCE)
- −88.9%
- Liabilities / assets
- 30.5%
- Debt / equity
- 0.44×
- Book value / share
- $0.27
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Altman Z″ (distress)
- -30.78distress
- Accruals / assets
- −12.5%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Other material eventAug 9, 2021
- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Amended charter or bylaws · Other material eventJul 29, 2021
- Other material eventJul 23, 2021
- Other material eventJul 16, 2021
- Shareholder voteJun 22, 2021
- Entered a material agreementApr 30, 2021
- Entered a material agreement · Regulation FD disclosureMar 15, 2021
- Director / officer changeFeb 8, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.